TISSUE & FFPE COHORT COLLECTIONS

Prostate cancer tissue microarrays & FFPE blocks

Compare prostate cancer arrays by disease context, Gleason information and tissue composition, including selected hormone-refractory and progression collections. For FFPE blocks, share your tissue and study requirements with our team.

THE ARRAYS

Prostate cancer arrays (7)

Collection types in this TMA catalog

Explore the tissue composition and sampling groups represented in these arrays.

Data labels reflect the catalog record. Review each product and datasheet for case-level coverage. Array counts do not indicate stock availability.

FFPE TISSUE BLOCKS

Prostate cancer FFPE blocks for your study

Prostate FFPE profiles include metastatic disease, castration-resistant disease, PSMA-positive mCRPC and neuroendocrine prostate carcinoma.

FFPE blocks are requested by inquiry. Our team confirms tissue availability, donor matching and data coverage for your study.

Explore Prostate cancer FFPE cohort profiles

Collection features

  • Advanced disease (III/IV)
  • Longitudinal data
  • Pre / post standard-of-care treatment

Features vary by profile and donor; confirm the required coverage for your study.

Profiles describe documented collections, not live inventory. Features vary by profile and donor. Pre/post treatment collections are not necessarily donor-matched; availability and required coverage are confirmed for your study.

SELECTING YOUR ARRAY

Selecting prostate cancer tissue for your study

Compare the represented tissue and the available records before choosing an array. These examples describe individual catalog entries; data coverage is specific to each array.

Hormone-Refractory Prostate Cancer TMA

This hormone-refractory prostate cancer tissue microarray is listed with Gleason scores. The hormone-refractory setting and grading information distinguish it from prostate arrays defined only by histopathology.

Prostate Cancer TMA: Matched Nodal Metastases

This prostate cancer tissue microarray includes primary tumors and matched nodal metastases with histopathology data. Nodal tissue is the specified metastatic component of this collection.

RNAscope HRPC/CRPC TMA: Pre/Post Treatment

This RNAscope-prequalified metastatic HRPC/CRPC tissue microarray includes pre- and post-treatment samples with follow-up data. The pre/post groups are not donor matched.